XANTHINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS

Details for Australian Patent Application No. 2003249604 (hide)

Owner CV THERAPEUTICS, INC.

Inventors KALLA, Rao; PERRY, Thao; ELZEIN, Elfatih; VARKHEDKAR, Vaibhav; LI, Xiaofen; IBRAHIM, Prabha; PALLE, Venkata; XIAO, Dengming; ZABLOCKI, Jeff

Agent Freehills

Pub. Number AU-A-2003249604

PCT Number PCT/US03/14085

PCT Pub. Number WO2004/106337

Filing date 6 May 2003

Wipo publication date 21 January 2005

Acceptance publication date 30 June 2011

International Classifications

C07D 473/06 Heterocyclic compounds containing purine ring systems

Event Publications

16 October 2003 Complete Application Filed

10 February 2005 Application Open to Public Inspection

  Published as AU-A-2003249604

15 October 2009 Alteration of Name

  The name of the applicant has been altered to Gilead Palo Alto, Inc.

30 June 2011 Application Accepted

  Published as AU-A-2003249604

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003249605-METHOD AND APPARATUS FOR REDUCING POWER OF A CDMA MOBILE STATION BY CONTROLLED TRANSITION FROM CONTROL HOLD TO ACTIVE STATE

2003249603-SYSTEM FOR PROVIDING BROADBAND MOBILE ACCESS FROM GEOSTATIONARY SATELLITES TO PLATFORMS USING SMALL, LOW PROFILE ANTENNAS